The O-linked oligosaccharides (O-glycans) in mammalian glycoproteins are classified according to their core structures. Among the most common is the core 1 disaccharide structure consisting of Gal␤133GalNAc␣13Ser/ Thr, which is also the precursor for many extended Oglycan structures. The key enzyme for biosynthesis of core 1 O-glycan from the precursor GalNAc-␣-Ser/Thr is UDP-Gal:GalNAc-␣-Ser/Thr ␤3-galactosyltransferase (core1 ␤3-Gal-T). Core 1 ␤3-Gal-T activity, which requires Mn 2؉ , was solubilized from rat liver membranes and purified 71,034-fold to apparent homogeneity (>90% purity) in 5.7% yield by ion exchange chromatography on SP-Sepharose, affinity chromatography on immobilized asialo-bovine submaxillary mucin, and gel filtration chromatography on Superose 12. The purified enzyme is free of contaminating glycosyltransferases. Two peaks of core 1 ␤3-Gal-T activity were identified in the final step on Superose 12. One peak of activity contained protein bands on non-reducing SDS-PAGE of ϳ84-and ϳ86-kDa disulfide-linked dimers, whereas the second peak of activity contained monomers of ϳ43 kDa. Reducing SDS-PAGE of these proteins gave ϳ42-and ϳ43-kDa monomers. Both the 84/86-kDa dimers and the 42/43-kDa monomers have the same novel N-terminal sequence. The purified enzyme, which is remarkably stable, has an apparent K m for UDP-Gal of 630 M and an apparent V max of 206 mol/mg/h protein using GalNAc␣1-O-phenyl as the acceptor. The reaction product was generated using asialo-bovine submaxillary mucin as an acceptor; treatment with O-glycosidase generated the expected disaccharide Gal␤133GalNAc. These studies demonstrate that activity of the core 1 ␤1,3-Gal-T from rat liver is contained within a single, novel, disulfide-bonded, dimeric enzyme.
The addition of O-glycans to proteins is a common posttranslational modification on many secreted and membranebound glycoproteins (1) (2) (3) (4) . The mucin-type O-glycans, which contain a core GalNAc in ␣-glycosidic linkage to Ser or Thr, are synthesized in the Golgi apparatus by the sequential action of glycosyltransferases that transfer individual sugars from nucleotide sugar donors (5, 6) . Whereas all mucin-type O-glycans contain the common GalNAc␣1-Ser/Thr linkage, at least eight different O-glycan core structures have been described that differ in the types of sugars and their linkage. Two of the most common mucin-type O-glycans are based on the core 1 and core 2 structures. Core 1 has the disaccharide structure Gal␤133GalNAc␣13 R and core 2 has the trisaccharide structure Gal␤133(GlcNAc␤136)GalNAc␣13 R. In addition to serving as an precursor to the core 2 structure, the core 1 can also be modified by sialylation and fucosylation to generate a wide range of other structures (3) . Alternatively, the unmodified core 1 disaccharide is recognized as a cancer-associated antigen (T-or Thomsen-Friedenreich antigen) (1) . In addition, the core 1 O-glycan may be directly extended by addition of GlcNAc to form an extended core 1 structure (7) (8) (9) .
The core 1 disaccharide is synthesized by the action of an enzyme activity designated the core 1 UDP-Gal:GalNAc-␣-R ␤1,3-galactosyltransferase (core 1 ␤3-Gal-T, EC 2.4.1.122), where R is Ser/Thr through direct transfer to the acceptor ␣-linked GalNAc. Thus, the core 1 ␤3-Gal-T may be considered to play a pivotal and decisive role in mucin and glycoprotein biosynthesis. However, although the core 1 ␤3-Gal-T activity is present in most mammalian tissue, the enzyme has not been purified to homogeneity, and the possible diversity of different enzymes with this activity is unknown (10, 11) . The core 1 O-glycan structure is required for the action of the core 1 ␤1,6-N-acetylglucosaminyltransferase (core 2 GlcNAc-transferase), which allows synthesis of core 2-based O-glycans of the sequence Gal␤134GlcNAc␤136 (Gal␤133)GalNAc␣13 Ser/ Thr (6, (12) (13) (14) (15) . The sialylated and fucosylated derivative of a core 2-based O-glycan is required for recognition of the leukocyte mucintype ligand PSGL-1 by P-selectin (9, 16) . The inability to express the core 1 ␤3-Gal-T results in expression of truncated O-glycans, such as the unsubstituted GalNAc␣13Ser/Thr (Tn antigen) or the sialylated derivative NeuAc␣236GalNAc␣13Ser/Thr (sialyl Tn antigen). Expression of the Tn and sialyl-Tn antigens has been associated with tumor progression (17, 18) . Several tumor cell lines, including Jurkat, a human T leukemic cell line (19) , and LSC cells, a human colon carcinoma cell line (20) , express sialyl Tn antigen, which appears to result from a lack of the core 1 ␤3-Gal-T activity.
Core 1 ␤3-Gal-T may play an important role in other diseases, such as Tn syndrome and IgA nephropathy. It has been proposed that exposure of the Tn antigen in erythrocytes (Tn syndrome) (1) and in the hinge region of IgA (IgA nephropathy) (21) (22) (23) results in immune recognition and attack by a naturally circulating anti-Tn. These diseases may be caused by deficiency of core 1 ␤3-Gal-T (24 -26), but the exact pathogenesis is unknown because the core 1 ␤3-Gal-T has not been purified, and the gene(s) encoding core 1 ␤3-Gal-T has not been cloned.
As a step toward the cloning of the gene(s) encoding the core 1 ␤3-Gal-T, in this paper we describe the ϳ71,000-fold purification of core 1 ␤3-Gal-T from rat liver to apparent homogeneity and the characterization of the purified protein. N-terminal sequencing demonstrates that a single polypeptide was purified that exists as an active monomer and as a disulfide-bonded dimer. This is the first isolation of a core 1 ␤3-Gal-T.
EXPERIMENTAL PROCEDURES

Materials
GalNAc␣1-O-phenyl, Gal␤1,3GalNAc-␣-phenyl UDP-Gal, DTT, ATP, UDP, PMSF, benzamidine, leupeptin, pepstatin A, Triton X-100, bovine submaxillary mucin (type I-S), and the disaccharides Gal␤1-3GalNAc, Gal␤1-4GlcNAc, Gal␤1-6GalNAc, Gal␤1-6Gal, and Gal␤1-3GlcNAc were obtained from Sigma. MES, MOPS, Tris, methanol, 1-butanol, and scintiverse-BD were obtained from Fisher. UDP- [6- 3 H]Gal (40 -60 Ci/ mmol) was obtained from American Radiolabeled Chemicals, Inc. The BCA protein assay kit and the UltraLink TM Bio-support Medium were obtained from Pierce. Peptide N-glycosidase F (N-glycanase) and Oglycosidase were obtained from Roche Molecular Biochemicals. Sep-Pak C 18 cartridges was obtained from Waters Associates. Precast SDS-PAGE gels were obtained from Invitrogen/NOVEX. Mixed bed resin AG 501-X8 was obtained from Bio-Rad. The synthetic glycopeptide 4-GP-1 with the sequence Glu-Tyr-Glu-Tyr-Leu-Asp-Tyr-Asp-Phe-Leu-ProGlu-(GalNAc␣1-O-Thr)-Glu-Pro-Pro-Glu-Met and having the GalNAcsubstituted Thr, as indicated, was synthesized as described in Leppänen et al. (16) . Triose (GlcNAc␤1,3Gal␤1,4Glc) was prepared by treatment of the tetrasaccharide LNneoT (Gal␤1,4GlcNAc␤1,3Gal␤1,4Glc) with jack bean ␤-galactosidase and subsequent purification of the trisaccharide (triose) from the released galactose by gel filtration on a column (3 ϫ 200 cm) of Bio-Gel P-2 equilibrated in water.
Core 1 ␤3-Gal-T Assay
The assay for core 1 ␤3-Gal-T contained 100 mM MES, pH 6.8, 0.2% Triton X-100, 20 mM MnCl 2 , 1 mM GalNAc␣1-O-phenyl, 0.4 mM UDP-[ 3 H]Gal (100,000 -150,000 dpm/nmol), 2 mM ATP, and 5-25 l of enzyme in a total volume of 50 l. Mixtures were incubated at 37°C for 30 -60 min and stopped by adding 950 l of cold H 2 O. The mixtures were loaded onto 500-mg Sep-Pak C 18 cartridges, previously activated with 2 ml of ethanol and equilibrated with 10 ml of water. Following application of the diluted reaction mixture, the columns were washed with 15 ml of water, eluted with 2 ml of 1-butanol, and radioactivity determined by liquid scintillation counting in 10 ml of Scintiverse-BD. A unit of activity is defined as that amount of enzyme transferring 1 nmol of Gal from UDP-Gal to the acceptor GalNAc␣1-O-phenyl per h at 37°C. When the synthetic glycopeptide 4-GP-1 was used as an acceptor, the assays were conducted as above substituting the 4-GP-1 for GalNAc␣1-O-phenyl, except that methanol, rather than 1-butanol, was used for elution of product glycopeptides from the Sep-Pak C 18 cartridges.
UDP-GlcNAc:Gal␤1,3GalNAc-R(GlcNAc to GalNAc)
␤6-GlcNAc Transferase (Core 2 ␤6-Gn-T) Assay
Core 2 ␤6-Gn-T activities were measured in a total volume of 50 l containing 0.1 M MES (pH 6.5), 0.125% Triton X-100, 10 mM ATP, 0.125 M GlcNAc, 2 mM Gal␤1,3GalNAc-␣-phenyl, 1 mM UDP-[ 3 H]GlcNAc (10 cpm/pmol), and 20 l of enzyme sample. The reactions were incubated at 37°C for 1.5 h, and the product was estimated by Sep-Pak C 18 column, as described above for the core 1 ␤3-Gal-T assay.
UDP-GlcNAc:GalNAc-␣-R ␤3-GlcNAc Transferase (Core 3
␤3-Gn-T) Assay
Core 3 ␤3-Gn-T activities were measured in a total volume of 50 l containing 0.1 M MES (pH 6.5), 15 mM MnCl 2 , 0.2% Triton X-100, 10 mM ATP, 4 mM GalNAc-␣-phenyl, 1 mM UDP-[ 3 H]GlcNAc (10 cpm/pmol), and 20 l of enzyme samples. The reactions were incubated at 37°C for 1.5 h, and the product was estimated by Sep-Pak C 18 column, as described above for the core 1 ␤3-Gal-T assay.
UDP-Gal:GlcNAc ␤1,4 Galactosyltransferase (␤4-Gal-T) Assay
␤4-Gal-T activities were measured in a total volume of 50 l containing 0.1 M Tris-HCl (pH 7.2), 15 mM MnCl 2 , 0.2% Triton X-100, 10 mM ATP, 5 mM GlcNAc␤1,3Gal␤1,4Glc (triose), 0.4 mM UDP-[ 3 H]Gal (20 cpm/pmol), and 20 l of enzyme samples. The reactions were incubated at 37°C for 1.5 h, and the product was estimated following chromatography on QAE-Sephadex A-25 (1 ml) column and measurement of the unbound radioactivity.
GDP-Fucose:GlcNAc ␣1,3-Fuc-transferases (␣1,3-Fuc-T) Assay
␣1,3-Fuc-T activities were measured in a total volume of 50 l containing 0.1 M MES (pH 6.5), 15 mM MnCl 2 , 0.2% Triton X-100, 10 mM ATP, 10 mM Gal␤1,4GlcNAc␤1,3Gal␤1,4Glc (LNnT), 0.4 mM GDP-[ 3 H]fucose (20 cpm/pmol), and 20 l of enzyme samples. The reactions were incubated at 37°C for 1.5 h, and the product was estimated following chromatography on QAE-Sephadex A-25 (1 ml) column and measurement of the unbound radioactivity.
CMP-NeuAc:GalNAc-␣-R ␣2,6-Sialyltransferase (␣2,6-ST) Assay ␣2,6-ST activities were measured in a total volume of 100 l containing 0.1 M MES (pH 6.5), 5 mM EDTA, 0.2% Triton X-100, 10 mM ATP, 150 g of asialo-BSM, 1 mM CMP-[ 3 H]NeuAc (10 cpm/pmol), and 20 l of enzyme samples. The reactions were incubated at 37°C for 1.5 h. The reaction mixture was diluted with 400 l of H 2 O and 500 l of ice-cold 10% trichloroacetic acid. The mixtures were kept on ice for 30 min and centrifuged at 14,000 ϫ g for 10 min. The pellets were washed with 1 ml of cold 0.01% HCl in acetone 3 times and dried on a speed-vac concentrator. The dried residues were dissolved in 0.5 ml of 0.2 N KOH and mixed with 5 ml of ScintiVerse-BD and counted.
Preparation of Asialo-BSM UltraLink
TM
Bovine submaxillary mucin (BSM) (100 mg) was dissolved in 20 ml of 0.1 M MOPS and 0.6 M sodium citrate (pH 7.5), and coupled to 0.6 g of UltraLink TM beads overnight at 4°C, followed by blocking with 3 M ethanolamine (1 h, 20°C). Following washing with 1 M NaCl and equilibration with water, the coupled BSM (ϳ3 mg/ml) was desialylated by incubation with an equal volume of 2 N HCl at 100°C for 90 s. The beads were then chilled in ice, neutralized with NaOH, and equilibrated with buffer 50 mM Tris-HCl (pH 7.0), 150 mM NaCl, and 20 mM MnCl 2 .
Purification of Core 1 ␤3-Gal-T
Step 1: Homogenization, Subcellular Fractionation, Isolation of Membranes, and Solubilization-Rat liver (500 g) was freshly obtained and washed with cold 150 mM NaCl in 25 mM Tris-HCl (pH 7.4) and homogenized with 2,000 ml of 25 mM Tris-HCl (pH 7.5) and 0.25 M sucrose containing 1 mM dithiothreitol (DTT), 1 mM PMSF, 2 g/ml leupeptin, 1 mM benzamidine, and 0.7 g/ml pepstatin A in a Waring commercial blender. In all steps of the purification, protein was determined by absorbance at 280 nm or by the BCA assay (Pierce) according to the manufacturer's protocol using bovine serum albumin as a standard. The homogenate was centrifuged at 1,000 ϫ g for 30 min, and the supernatant was decanted and centrifuged at 100,000 ϫ g for 60 min. The pellets were suspended in 5 volumes of 50 mM Tris-HCl (pH 9.0) and 0.25 M sucrose containing 2% Triton X-100, 1 mM PMSF, 2 g/ml leupeptin, 1 mM benzamidine, and 0.7 g/ml pepstatin A and sonicated for 10 s four times in an ice bath. These sonicated membranes were solubilized on ice for 1 h and then centrifuged at 100,000 ϫ g for 60 min. The supernatant was collected (ϳ1,000 ml) and the pH was adjusted to 6.5 using 1 M MES.
Step 2: SP-Sepharose Chromatography-The extracted membrane preparation was applied to a column of SP-Sepharose FF (6 ϫ 20 cm; Amersham Biosciences), previously equilibrated with 25 mM MES (pH 6.5), 0.1% Triton, 5 mM MnCl 2 , containing 1 mM PMSF, 2 g/ml leupeptin, 1 mM benzamidine, and 0.7 g/ml pepstatin A. By using the same buffer, the column was washed, and the core 1 ␤3-Gal-T was eluted in one step by application of 1 M NaCl in equilibrating buffer.
Step 3: Asialo-BSM-UltraLink TM Chromatography-The eluate from the SP-Sepharose column was dialyzed and concentrated down to 50 ml using an Omicon concentrator. The concentrated sample was loaded onto a column of asialo-BSM-Ultralink TM (1.2 ϫ 5 cm) equilibrated with 25 mM Tris-HCl (pH 7.0), 0.01% Triton X-100, 20 mM MnCl 2 , 150 mM NaCl, containing 1 mM PMSF, 2 g/ml leupeptin, 1 mM benzamidine, and 0.7 g/ml pepstatin A. After washing the column in the same buffer, the core 1 ␤3-Gal-T was eluted with 1 M NaCl in the buffer lacking Mn 2ϩ . Fractions (1 ml) were collected, and activity of core 1 ␤3-Gal-T was assayed. Fractions containing the core 1 ␤3-Gal-T activity were pooled.
Step 4: Superose 12 Chromatography-The core 1 ␤3-Gal-T from Asialo-BSM UltraLink TM was concentrated down to 200 l, using Cen-triprep 30 and Centricon 30 (Omicon), and loaded on Superose 12 (1.0 ϫ 35 cm; Amersham Biosciences), which was pre-equilibrated with 25 mM Tris-HCl (pH 7.2), 0.005% Triton X-100, and 150 mM NaCl. Core 1 ␤3-Gal-T was eluted with the same buffer, and fractions (0.25 ml) were collected and assayed for activity. Two peaks of activity were recovered from the Superose 12 step, and those fractions containing peak levels of activity were pooled. This pooled material represented the purified core 1 ␤3-Gal-T.
SDS-PAGE
SDS-PAGE was performed in Tris glycine buffer on precast acrylamide gradient gels (NOVEX) as described by the manufacturer. Proteins were visualized by silver staining (27) . Gels were scanned on a UMAX Astra 2100U Scanner. Stained protein bands were identified and quantified by scanning using the NIH Image program (rsb.info.nih.gov/nih-image/).
Generation of 3 H-Galactosylated Asialo-BSM
To effect desialylation, bovine submaxillary mucin (BSM) (5 mg) was dissolved in 0.80 ml of 1 N HCl and incubated at 100°C for 90 s and then cooled in ice. The reaction mixture was neutralized with NaOH and desalted on a G-25 Sephadex, PD-10 column (Amersham Biosciences) equilibrated with water. The void volume was collected and concentrated to 1 ml in a Centriprep-30 and designated asialo-BSM. This acceptor was used directly for the core 1 ␤3-Gal-T reaction. The reaction mixture in 100 l total volume contained asialo-BSM (160 g), UDP-[ 3 H]Gal (0.4 mM) (100,000 dpm total), Triton X-100 (0.2%), ATP (2 mM), MnCl 2 (20 mM), and purified core 1 ␤3-Gal-T (20 units of activity). The reaction mixture was incubated at 37°C for 2 h and then applied to a column of Sephadex G-25 (0.5 ϫ 6 cm; Superfine; Amersham Biosciences) and eluted with water. Fractions (ϳ100 l) were collected and pooled, and the first radioactive peak was concentrated to 50 l.
Identification of the Enzymatic Reaction Product
The product using asialo-BSM as an acceptor was treated with Oglycosidase in a total reaction volume of 100 l by adding 25 mM Tris-HCl (pH 7.4), 150 mM NaCl, and O-glycosidase (ϳ12.5 milliunits) and a drop of toluene. This reaction mixture was incubated at 37°C for 48 h. The whole sample was then applied to a column of Sephadex G-25 (Superfine) and eluted with H 2 O. Fractions (100 l) were collected, and the radioactive peak was pooled and passed through 1-ml mixed bed resin (Bio-Rad), and the column was washed with 5 ml of H 2 O. The product was collected and dried in vacuo. The dried core 1 ␤3-Gal-T product was dissolved in 25 l of H 2 O and mixed with 15 l containing 2.5 l of 1 mg/ml authentic Gal␤1-3GalNAc standard. The mixed sample was analyzed on a Dionex HPAEC (Dionex Corp.) equipped with a PA-1 column (4 ϫ 250 mm) and pulsed amperometric detector. Fractions (0.33 ml) were collected, and the elution of the radioactive product was monitored by liquid scintillation counting. The elution positions of the unlabeled standards Gal␤1-3GalNAc, Gal␤1-4GlcNAc, Gal␤1-6GalNAc, Gal␤1-6Gal, and Gal␤1-3GlcNAc was directly determined for each individual glycan using pulsed amperometric detection.
N-terminal and Internal Amino Acid Sequence of Core 1 ␤3-Gal-T
Purified core 1 ␤3-Gal-T (ϳ10 g) was analyzed on a 4 -12% SDS-PAGE (NOVEX) under non-reducing conditions and then transferred to a polyvinylidene difluoride membrane (Applied Biosystems, Inc.). After staining with Coomassie Brilliant Blue, the top two bands of 84 and 86 kDa (Fig. 3) , respectively, were excised and the N-terminal sequence determined by Edman degradation (Applied Biosystems, Inc. protein sequencer). Similarly, the protein band at 42/43 kDa in non-reducing SDS-PAGE (Fig. 3 ) was excised and the N-terminal sequence determined by Edman degradation. To obtain internal peptide sequence, purified enzyme (ϳ5 g) was resolved by SDS-PAGE (4 -12%) under non-reducing conditions, and the top two bands of 84/86 kDa were excised from the gel. These proteins were digested in situ with trypsin, and tryptic peptides were isolated by reverse-phase high pressure liquid chromatography. The size of one purified peptide was determined by matrix-assisted laser-desorption/ionization-mass spectrometry (MALDI-MS) and confirmed by direct sequencing by Edman degradation at the Yale University Protein Sequencing Facility.
RESULTS
Characterization of the Core 1 ␤3-Gal-T Assay
Rat liver was chosen as a tissue source for the purification of core 1 ␤3-Gal-T, because our preliminary experiments demonstrated that rat liver homogenates contain relatively high core 1 ␤3-Gal-T activity compared with other organs. Core 1 ␤3-Gal-T was assayed by monitoring the transfer of [ 3 H]Gal from UDP-[ 3 H]Gal to the synthetic acceptor GalNAc␣1-O-phenyl. The product was isolated by Sep-Pac chromatography by exploiting the hydrophobicity of the acceptor and product. Core 1 ␤3-Gal-T activity in the solubilized rat liver membrane fraction was linear with respect to added protein from 50 to 400 g (Fig.  1A) . Activity was also linear with respect to time between 20 and 90 min (Fig. 1B) . The core 1 ␤3-Gal-T activity demonstrated an absolute requirement for divalent cation, with optimal activity being observed with 10 mM Mn 2ϩ (Fig. 1C) .
Rat Liver Core 1 ␤3-Gal-T Is a Membrane-associated Protein
To investigate whether rat liver core 1 ␤3-Gal-T was membrane-associated, the post-nuclear supernatant fraction of rat liver homogenates was centrifuged at 106,000 ϫ g for 60 min. Greater than 97% of the enzyme activity was pelleted under these conditions (data not shown). Detergent (2% Triton X-100), but not 1 M NaCl, caused the quantitative release of core 1 ␤3-Gal-T activity from the membrane into the 106,000 ϫ g supernatant, indicating the enzyme is membrane-associated.
Purification of Core 1 ␤3-Gal-T
The protocol developed for purification of the core 1 ␤3-Gal-T from rat liver resulted in a 71,034-fold purification, as summarized in Table I and as discussed below. Steps 1 and 2: Homogenization, Subcellular Fractionation, and Isolation of Membranes and Solubilization-Rat livers were homogenized, and the homogenate was centrifuged to obtain a post-nuclear supernatant. The membranes in the postnuclear supernatant were collected by centrifugation at 100,000 ϫ g for 60 min, and the supernatant was decanted and discarded. This membrane preparation was solubilized in buffer containing 2.0% Triton X-100. Enzyme assays demonstrated that this solubilized membrane preparation contained core 1 ␤3-Gal-T activity at 9.8 nmol/h/mg protein, and Ͻ10% of the activity remained in the unsolubilized material.
Step 3: SP-Sepharose FF Chromatography-The solubilized membrane proteins from step 2 were chromatographed on a column of the anion exchanger SP-Sepharose. Elution of bound proteins was carried out in a single step by application of 1 M NaCl in buffer (data not shown). With this step the core 1 ␤3-Gal-T was purified ϳ3-4-fold with 31.3% recovery. Although the degree of purification and recovery was not high, this procedure was necessary to separate contaminating proteins, including some glycosidases, from the core 1 ␤3-Gal-T activity.
Step 4: Asialo-BSM-UltraLink TM Chromatography-Bovine submaxillary mucin contains a variety of short core 1 type O-glycans including sialyl Tn (28) . Desialylation exposes the Tn antigen, thus making asialo-BSM an excellent acceptor substrate for the core 1 ␤3-Gal-T. During the course of trying different affinity approaches, we discovered that core 1 ␤3-Gal-T bound tightly to a column of asialo-BSM-Ultralink TM in the presence of Mn 2ϩ . The enzyme was eluted as a broad peak from this column with using buffer containing 1 M NaCl and lacking Mn 2ϩ ( Fig. 2A) . This affinity step was the most important step for purification, resulting in an increase of specific activity to 162,333 from 33.8 nmol/hr/mg with a 4,802-fold purification.
Step 5: Superose 12 Chromatography-The core 1 ␤3-Gal-T from the asialo-BSM affinity column was then further purified by gel filtration chromatography on Superose 12 (Fig. 2B) . Core 1 ␤3-Gal-T was recovered in a broad peak with ϳ65% recovery from this column. This 5-step protocol resulted in a 71,034-fold purification of the core 1 ␤3-Gal-T from rat liver homogenates, with a 5.7% yield and a total of 41 g of total protein at ϳ15 g/ml (Table I) .
SDS-PAGE
The core 1 ␤3-Gal-T activity from Superose 12 was analyzed by SDS-PAGE under non-reducing conditions, and the protein was detected by silver staining (Fig. 2C) . The activity of the core 1 ␤3-Gal-T from the Superose 12 column was associated with three major protein bands of ϳ84 and 86 kDa (fractions 32-40) and ϳ43 kDa (e.g. fraction 50), which were also apparent in the starting material (Fig. 2C) . In multiple analyses we found that activity of core 1 ␤3-Gal-T consistently correlated with elution of these major protein peaks from Superose 12 (Fig. 2, B and C) . The fractions 32-40 and 49 -51 from the Superose 12 column were pooled, and these represent the purified rat liver core 1 ␤3-Gal-T. The analysis of the purity of this pooled material by SDS-PAGE is below.
These data suggested that the core 1 ␤3-Gal-T occurs as an ϳ43-kDa monomer and an 84/86-kDa dimer. To define whether the 84/86 kDa was a disulfide-bonded dimer of the ϳ43-kDa monomers, the purified core 1 ␤3-Gal-T was analyzed in reducing versus non-reducing SDS-PAGE. The results in Fig. 3 (top) show that in non-reducing SDS-PAGE the major material is a doublet of 84/86 kDa with minor bands at 42/43 kDa. A scan of the material in the non-reduced purified core 1 ␤3-Gal-T is shown in Fig. 3 (bottom) and reveals that Ͼ90% of detectable protein is contained within the doublet of 84/86 kDa and the minor bands at 42/43 kDa. However, in reducing SDS-PAGE the major material occurs as a close doublet of the 42/43-kDa proteins (Fig. 3, top) . These results indicate that the 84/86-kDa material represents a disulfide-bonded dimeric form of the core 1 ␤3-Gal-T, which upon reduction behaves as a doublet of 42/43-kDa proteins. This interpretation is confirmed by direct protein sequencing, as described below in more detail.
To assess further purity of the core 1 ␤3-Gal-T, we assayed the purified enzyme for the presence of contaminating glycosyltransferases that might co-purify with the enzyme. We also tested the initial rat liver homogenate as a control. The enzymes tested included the UDP-GlcNAc:Gal␤1,3GalNAc-R(GlcNAc to GalNAc) ␤6-GlcNAc-transferase (core 2 ␤6-Gn-T), UDP-GlcNAc:GalNAc-␣-R ␤3-GlcNAc-transferase (core 3 ␤3-Gn-T), UDP-Gal:GlcNAc ␤1,4-galactosyltransferase (␤4-Gal-T), GDP-fucose:GlcNAc ␣1,3-Fuc-transferases (␣1,3-Fuc-T), and CMP-NeuAc:GalNAc-␣-R ␣2,6-sialyltransferase (␣2,6-ST). Each enzyme was assayed with specific acceptors and radiolabeled sugar nucleotide donors (Table II) , and the products were isolated and identified as described under "Experimental Procedures". All enzyme activities, except for the core 3 ␤3-Gn-T, were detected in the rat liver homogenate. However, the purified core 1 ␤3-Gal-T did not contain detectable levels of any other enzyme assayed (Table II) . These results are consistent with SDS-PAGE analyses and confirm that the core 1 ␤3-Gal-T from rat liver is highly purified.
We considered the possibility that the different sizes observed for the purified core 1 ␤3-Gal-T could result of differential glycosylation. However, the apparent molecular weight of the purified core 1 ␤3-Gal-T was not directly altered by treatment with peptide N-glycosidase F (N-glycanase) to remove potential N-glycans (data not shown). Subsequent cloning of the cDNA encoding this human enzyme and expression of the Purification of Core 1 ␤1,3-Galactosyltransferaserecombinant purified core 1 ␤3-Gal-T, as reported in the accompanying manuscript (61) , confirms that the human purified core 1 ␤3-Gal-T lacks N-glycans, because it lacks any potential N-glycosylation sequons. That study also suggests that the core 1 ␤3-Gal-T has few if any other types of post-translational glycosylation, such as O-glycans.
N-terminal and Internal Amino Acid Sequence
To define directly the relationship between the 84/86-kDa dimers and the 42/43-kDa monomers, we sequenced the N terminus of the 84-and 86-kDa proteins separately and the combined 42/43-kDa monomers. The results shown in Fig. 4 demonstrate that the 84-and 86-kDa material have identical N-terminal sequences to the combined 42/43-kDa material. These results and the behavior of the 84/86-kDa material in reducing SDS-PAGE demonstrate that the 84/86-kDa material represents dimeric forms of the 42/43-kDa monomeric material. These results also indicate that all detectable protein by SDS-PAGE analysis of the non-reduced core 1 ␤3-Gal-T (Fig. 3 , top and bottom) are contained within the 84/86-and 42/43-kDa bands. Furthermore, these results are consistent with the scan of the purified material (Fig. 3, bottom) indicating that the enzyme is Ͼ90% pure. SDS-PAGE analysis of the reduced core 1 ␤3-Gal-T (Fig. 3, top) showed the presence of some other minor protein bands primarily of lower size than the 42/43-kDa bands. Because direct protein sequencing of all detectable protein in the non-reduced material (Fig. 3, top and bottom, Fig. 4) showed that all proteins have the same N-terminal sequence, the other protein bands smaller than the 42/43-kDa material A, the pooled core 1 ␤3-Gal-T from SP-Sepharose was diluted to 0.2 M NaCl and concentrated to 50 ml in a CentriPrep 30. The concentrated sample was applied to a 5-ml column of asialo-BSM-UltraLink TM equilibrated in 25 mM Tris-HCl (pH 7.0) containing 150 mM NaCl, 20 mM MnCl 2 , and 0.01% Triton X-100-containing protease inhibitors. The column was washed with the same buffer and then eluted with 1 M NaCl in buffer lacking MnCl 2 at a flow rate of 0.5 ml/min. Fractions (1 ml) were collected and assayed for protein and core 1 ␤3-Gal-T activity. B, pooled, concentrated fractions containing core 1 ␤3-Gal-T activity from asialo-BSM-UltraLink TM were loaded on Superose 12 (1 ϫ 35 cm) and eluted with 25 mM Tris-HCl (pH 7.2), 150 mM NaCl, 0.005% Triton X-100 as described. C, non-reducing SDS-PAGE (4 -12% acrylamide) of starting material and indicated fractions eluted from Superose 12. Protein was visualized by silver staining. The activity of each fraction is indicated at the bottom of the gel. The positions of molecular size markers are indicated. may represent proteolytic fragments of the enzyme processed in the C terminus. Due to their minor nature, they were not analyzed further.
The monomeric form of the enzyme may arise during the brief treatment of the liver extract with DTT in early steps of the purification. The results from Superose 12 chromatography demonstrate that both the dimeric and monomeric forms of the enzyme are active. Interestingly, the core 1 ␤3-Gal-T must be active in reducing conditions, because the initial post-nuclear supernatant, which contained DTT, had fully active enzyme (Table I) . To obtain more sequence information the mass of one major tryptic peptide was identified and found to be 1385.1 Da by MALDI-MS and direct sequencing. The deduced primary structure of the internal peptide is also shown in Fig. 4 . It consists of 11 amino acids with a calculated molecular mass of 1384.53 Da, consistent with the mass found by MALDI-MS.
Identification of the Product of Core 1 ␤3-Gal-T
Asialo-BSM is an excellent acceptor of core 1 ␤3-Gal-T, and the reaction product from this acceptor was used to characterize the structure of the oligosaccharide generated by the activity. (29, 30) . The 3 H-labeled material released by O-glycosidase was recovered in included fractions following chromatography on Sephadex G-25 and further purified by passage over a mixed bed ion exchange column. The 3 H-labeled material was analyzed by high performance high pH anion exchange chromatography (HPAEC) on a Dionex PA-1 column and compared in its elution with the defined disaccharide standards. The radioactive product of the core 1 ␤3-Gal-T reaction released from asialo-BSM product by Oglycosidase eluted identically to the standard Gal␤133GalNAc (Fig. 5). (The leading edge of the peak of radioactive product in Fig. 5 was also seen in the elution of the standard Gal␤133GalNAc.) The combined evidence that the product of the reaction with the purified core 1 ␤3-Gal-T is released by the   FIG. 5 . Identification of product of core 1 ␤3-Gal-T. The purified core 1 ␤3-Gal-T was incubated with asialo-BSM and UDP-[ 3 H]Gal, and the product of the reaction was released from the acceptor by treatment with O-glycosidase. The released material was analyzed by high pH anion exchange chromatography on a Dionex PA-1 column. Several disaccharide standards were also analyzed, and their elution positions are shown.
TABLE II
Glycosyltransferase activities in rat liver homogenate and purified core 1 ␤3-Gal-T from rat liver a Different glycosyltransferases were assayed using specific acceptors and sugar nucleotide donors. The two enzyme sources assayed were the rat liver homogenate and purified core 1 ␤3-Gal-T, as described under "Experimental Procedures." The 84 and 86 kDa in the purified core 1 ␤3-Gal-T were excised from SDS-PAGE (Fig. 3) , as described under "Experimental Procedures," and their N-terminal sequences were identified. Similarly the 42/43-kDa protein band (Fig. 3) was excised and the N-terminal sequence identified. Internal peptide sequence was obtained by MALDI-MS following trypsinization of the 84/86-kDa proteins. The tryptic peptides were resolved by reverse-phase high pressure liquid chromatography, and sequenced by Edman degradation, as described under "Experimental Procedures." substrate-specific O-glycosidase and the released product has identical elution with authentic Gal␤133GalNAc upon Dionex HPAEC confirm that the purified core 1 ␤3-Gal-T synthesizes the expected core 1 product.
Characterization of the Enzyme Activity of the Purified
Core 1 ␤3-Gal-T
The kinetics of the purified core 1 ␤3-Gal-T toward the simple acceptor GalNAc␣1-O-phenyl and toward a complex glycopeptide with O-linked GalNAc were determined. For the acceptor GalNAc␣1-O-phenyl the apparent K m was 760 M (Fig. 6, A  and B) , and the apparent K m for UDP-Gal was 630 M (Fig. 7,  A and B, respectively) . The purified enzyme had an apparent V max of 206 mol/mg/h protein using GalNAc␣1-O-phenyl as the acceptor. An unusual feature of the purified core 1 ␤3-Gal-T was its relatively poor recognition of UDP, because unlike many other galactosyltransferases the core 1 ␤3-Gal-T was unable to bind efficiently to UDP-hexanolamine. As shown in Fig. 8 , the IC 50 for inhibition of the enzyme in rat liver detergent extracts by UDP was estimated to be ϳ1.4 mM. We also tested the ability of the purified core 1 ␤3-Gal-T to utilize as an acceptor the synthetic glycopeptide 4-GP-1, which was generated based on the proposed N-terminal sequence of the human P-selectin glycoprotein ligand-1 (PSGL-1) (9, 16) . This glycopeptide contains GalNAc␣1-Thr at a single position corresponding to Thr-57 in the native sequence. As shown in Fig. 6A , 4-GP-1 was an excellent acceptor and perhaps slightly better than GalNAc␣1-O-phenyl, although sufficient quantities of the synthetic glycopeptide were not available for use to determine precisely its K m value. DISCUSSION These results demonstrate that the rat liver core 1 UDP-Gal: GalNAc-␣-R ␤3-galactosyltransferase (core 1 ␤3-Gal-T) has been purified 71,034-fold. The protein occurs as a disulfidebonded dimer of 84/86 kDa and a monomeric species of 42/43 kDa. Both the dimeric and monomeric forms are enzymatically active. Like most of other glycosyltransferases, core 1 ␤3-Gal-T requires Mn 2ϩ for its activity. An unusual feature of the core 1 ␤3-Gal-T is its relatively high apparent K m for UDP-Gal of ϳ630 M and a remarkably high IC 50 for UDP of ϳ1.4 mM. Many other galactosyltransferases purified to date have relatively low K m values in the range of 10 -80 M, and the IC 50 and K i values of the enzymes for UDP are in the same range (31) (32) (33) (34) . Such a high K m value for UDP-Gal for the core 1 ␤3-Gal-T suggests a tight regulation of its activity by availability and concentration of sugar nucleotides and a strong dependence of its catalytic efficiency and rate on levels of enzyme. Whether the relatively high K m value of the core 1 ␤3-Gal-T for UDP-Gal plays a role in regulating its catalytic rate and efficiency is presently unknown. Although the subcellular localization of the core 1 ␤3-Gal-T is not known, FIG. 6 . Determination of the kinetics of the purified core 1 ␤3-Gal-T toward acceptor substrates. A, the purified core 1 ␤3-Gal-T was incubated with either GalNAc␣1-O-phenyl or a synthetic glycopeptide 4-GP-1, and the product formation was monitored as described under "Experimental Procedures." B, Lineweaver-Burk plot of the kinetic data using the acceptor GalNAc␣1-O-phenyl is shown. All analyses were performed in triplicate, and the S.D. was Ͻ5%.
FIG. 7.
Determination of the kinetics of the purified core 1 ␤3-Gal-T with the donor UDP-Gal. A, the purified core 1 ␤3-Gal-T was incubated with GalNAc␣1-O-phenyl and varying concentrations of UDP-Gal and product formation was monitored, as described under "Experimental Procedures." B, Lineweaver-Burk plot of the kinetic data using the donor UDP-Gal is shown. All analyses were performed in triplicate, and the S.D. was Ͻ5%.
FIG. 8.
Inhibition of the core 1 ␤3-Gal-T in membrane extracts by UDP. Ten l of core 1 ␤3-Gal-T in rat liver membrane extracts was incubated with 1 mM GalNAc␣1-O-phenyl, 0.4 mM UDP-Gal, and varying concentrations of UDP and product formation were monitored, as described under "Experimental Procedures." All analyses were performed in triplicate, and the S.D. was Ͻ5%.
it is likely that the enzyme acts after the polypeptide N-acetylgalactosaminyltransferases that initiates mucin-type O-glycan biosynthesis. These polypeptide GalNAc-transferases have been found in some cells to be localized diffusely throughout the Golgi apparatus (35) . Thus, the core 1 ␤3-Gal-T is likely to function within these same Golgi compartments, where other galactosyltransferases with lower K m requirements for UDPGal are also functioning. Direct enzyme assays demonstrated that the activity of the core 1 ␤3-Gal-T is co-localized with the ␤1,4-galactosyltransferase in the trans-Golgi (36) . This is consistent with findings by Hendricks et al. (37) that a 58-kDa resident protein of the cis-Golgi had terminal GalNAc residues in O-linkage. Thus, it is likely that the core 1 ␤3-Gal-T is localized in the distal Golgi compartments. However, more precise subcellular localization of the core 1 ␤3-Gal-T in many types of cells may require studies using specific antibodies to the enzyme. We are in the process of generating such antibodies for these studies.
The core 1 ␤3-Gal-T is like other so-called inverting glycosyltransferases in that it generates a ␤-linked product from an ␣-linked sugar nucleotide donor UDP-Gal. Recent crystal structures of inverting glycosyltransferases suggest that acceptor binding may depend on sugar nucleotide binding (38, 39) , such as seen for the ordered Bi Bi kinetics of N-acetylglucosaminyltransferase I. It would appear, however, that the core 1 ␤3-Gal-T might be an interesting exception to this observation, because we found that sugar nucleotide is not required for acceptor binding, because in the presence of Mn 2ϩ alone the enzyme binds tightly to its acceptor substrate asialo-BSM. However, it is possible that the core 1 ␤3-Gal-T could first bind either sugar nucleotide or acceptor and then bind the second reactant before proceeding with the reaction. It will be interesting in future studies to explore the crystal structure of the core 1 ␤3-Gal-T in complex with donor, acceptor, and metal. The lack of N-glycosylation and probable lack of other significant post-translational modifications may make the core 1 ␤3-Gal-T an excellent candidate for crystallization.
A critical and novel step in the purification of the rat liver core 1 ␤3-Gal-T is affinity chromatography on immobilized asialo-BSM. Asialo-BSM represents a type of natural mucin acceptor substrate of core 1 ␤3-Gal-T, and the enzyme binds so tightly to the support in the presence of Mn 2ϩ that it can only be eluted in a broad peak with high salt (e.g. 1 M NaCl) and only upon depletion of Mn 2ϩ . This is the most important step in the purification resulting in ϳ4800-fold purification. On SDS-PAGE under non-reducing conditions, the core 1 ␤3-Gal-T migrates as a doublet of 84 and 86 kDa with similar intensity, and both have the same N-terminal amino acid sequence. The size difference may result from either differential glycosylation or C-terminal cleavage. Under reducing SDS-PAGE the enzyme migrates as a close 42/43-kDa doublet, and these proteins share the same unique N terminus as the 84-and 86-kDa dimeric forms of the enzyme.
Despite the obvious importance of the core 1 ␤3-Gal-T to our overall understanding of mucin and glycoprotein biosynthesis, several previous studies (11, 40) have not been successful in purifying the enzyme to apparent homogeneity. It was reported earlier (41) that the core 1 ␤3-Gal-T was purified from swine trachea. However, the fold purification of the enzyme was Ͻ2,000-fold, and the purified protein was reported to have an apparent mass of 84 kDa in reducing SDS-PAGE. However, as we have shown the size of the purified enzyme from rat liver in reducing SDS-PAGE is 42/43 kDa. Furthermore, we have now cloned the cDNA encoding the core 1 ␤3-Gal-T from many different organisms, including humans, mice, rats, Caenorhabditis elegans, and Drosophila melanogaster, as described in the accompanying paper (61) . The sizes of the enzyme predicted from these sequences range from ϳ40 to 50 kDa. No sequence information was provided for the enzyme purified from swine trachea (41) , so the protein of 84 kDa that was "purified" remains unknown. It was also reported that core 1 ␤3-Gal-T purified from swine trachea has a K m for UDP-Gal of 20 M (41). By contrast, we find that the purified enzyme from rat liver has a K m for UDP-Gal of 630 M. Thus, it is clear that the enzyme purified from swine trachea is not likely to be similar to the core 1 ␤3-Gal-T we have purified from rat liver. In addition, some kinetic studies were carried out on the core 1 ␤3-Gal-T in a preparation from rat liver (11) . The activity in this preparation was enriched 170-fold and the preparation had other enzyme containing activities. By contrast, we have achieved ϳ71,000-fold purification of the core 1 ␤3-Gal-T from rat liver, and the purified enzyme was devoid of other potentially contaminating glycosyltransferase activities.
During the course of our many attempts to devise a strategy for purification of this enzyme, we have developed some insights into perhaps why this enzyme has presented unusual difficulties in purification. First, attempts to extract the enzyme in rat liver membranes with 2% Triton X-100 at ϽpH 8.5 resulted in extraction of Ͻ50% of the activity, whereas extraction with 2% Triton X-100 at pH 9.0 resulted in extraction of Ͼ90% of the activity. Second, many different galactosyltransferases that utilize UDP-Gal as the donor have been successfully purified by affinity chromatography on UDP-hexanolamine-Sepharose or a similar affinity support. However, we found that the rat liver core 1 ␤3-Gal-T does not bind immobilized UDP-hexanolamine even in the presence of Mn 2ϩ . Consistent with this finding is the unusually high IC 50 value for UDP (ϳ1.4 mM). Third, the enzyme binds tightly to immobilized asialo-BSM coupled to UltraLink, but binding requires the presence of Mn 2ϩ and omission of Mn 2ϩ in high salt for elution. Fourth, we also found that a significant difference between UltraLink and other affinity supports in that UltraLink demonstrates little if any nonspecific adsorption of protein. Although we cannot be certain, a combination of these factors may have contributed to previous difficulties in purifying this enzyme.
Several other glycosyltransferases have been shown to occur as disulfide-bonded homodimers, including ␤1,4 N-acetylgalactosaminyltransferase (GM2/GD2/GA2 synthase) (42, 43) , ␤1,4 galactosyltransferase (44, 45), human milk ␣1,3/4 fucosyltransferase (46), the spinach galactosyltransferase monogalactosyldiacylglycerol synthase (47) , and ␤-galactoside ␣2,6-sialyltransferase (48) . Interestingly, the dimeric form of the ␤-galactoside ␣2,6-sialyltransferase lacks catalytic activity but retains the ability to bind galactose (48) . Our studies demonstrate that both the dimeric and monomeric forms of the rat liver core 1 ␤3-Gal-T are enzymatically active. Although both forms may exist in the native state, the monomeric form may arise from the inclusion of DTT in the initial step of homogenization. More detailed studies will be needed to define the relative occurrence of the dimeric and monomeric forms of the core 1 ␤3-Gal-T in liver and other tissues. Nevertheless, our studies and those cited above raise many questions about the possible relationship between enzymatic properties and oligomerization for glycosyltransferases, which be important for regulating enzyme activity and targeting enzymes to correct subcellular compartments.
Many glycosyltransferases in vertebrates occur in relatively large gene families. These include the families of galactosyltransferases (49) , N-acetylgalactosaminyltransferases (50, 51) , fucosyltransferases (52, 53) , and sialyltransferases (54) . By contrast, several other glycosyltransferases in vertebrates are encoded by unique and single copy genes, such as N-acetylglucosaminyltransferases-I (55-58), -III (59), and ␣1-6-fucosyltransferase (60) . Although we obtained a doublet of protein bands of 84/86 and 42/43 kDa in SDS-PAGE, N-terminal sequencing indicated that all protein species have the same unique N terminus. This indicates that all rat liver core 1 ␤3-Gal-T activity is contained within a single polypeptide. To address this possibility, we describe in the accompanying manuscript (61) the cloning of the vertebrate gene encoding the core 1 ␤3-Gal-T. Those data demonstrate that the core 1 ␤3-Gal-T is encoded by a single gene, consistent with the finding of a single N terminus for the purified protein.
The availability of highly purified core 1 ␤3-Gal-T should have several important ramifications in the field of glycobiology. Already this enzyme has been used successfully to construct synthetic glycopeptides containing specifically placed O-glycans to allow exploration of the ligand binding specificity of human P-selectin (9, 16) . In addition, the availability of the core 1 ␤3-Gal-T and, as described in our accompanying manuscript (61), the gene encoding the enzyme will allow assessment of the postulated role of the core 1 ␤3-Gal-T in Tn syndrome and IgA nephropathy (1, 21, (23) (24) (25) (26) .
